International Journal of Radiation Oncology * Biology * Physics
Volume 75, Issue 2 , Pages 369-377 , 1 October 2009

Intra-Arterial Infusion Chemotherapy Using Cisplatin With Radiotherapy for Stage III Squamous Cell Carcinoma of the Cervix

  • Yuko Kaneyasu, M.D., Ph.D.

      Affiliations

    • Department of Radiation Oncology, Graduate School of Biomedical Sciences, Hiroshima University, Hiroshima, Japan
    • Corresponding Author InformationReprint requests to: Yuko Kaneyasu, M.D., Ph.D., Department of Radiation Oncology, Graduate School of Biomedical School Sciences, Hiroshima University, 1-2-3 Kasumi, Minamiku, Hiroshima 734-8551, Japan. Tel: (+81) 82-257-5257; Fax: (+81) 82-257-5259
    • ,
  • Nobutaka Nagai, M.D., Ph.D.

      Affiliations

    • Department of Obstetrics and Gynecology, Asa Citizen Hospital, Hiroshima, Japan
    • ,
  • Yasushi Nagata, M.D., Ph.D.

      Affiliations

    • Department of Radiation Oncology, Graduate School of Biomedical Sciences, Hiroshima University, Hiroshima, Japan
    • ,
  • Yasutoshi Hashimoto, M.D.

      Affiliations

    • Department of Radiation Oncology, Graduate School of Biomedical Sciences, Hiroshima University, Hiroshima, Japan
    • ,
  • Shintaro Yuki, M.D.

      Affiliations

    • Department of Radiation Oncology, Graduate School of Biomedical Sciences, Hiroshima University, Hiroshima, Japan
    • ,
  • Yuji Murakami, M.D., Ph.D.

      Affiliations

    • Department of Radiation Oncology, Graduate School of Biomedical Sciences, Hiroshima University, Hiroshima, Japan
    • ,
  • Masahiro Kenjo, M.D.

      Affiliations

    • Department of Radiation Oncology, Graduate School of Biomedical Sciences, Hiroshima University, Hiroshima, Japan
    • ,
  • Hideaki Kakizawa, M.D., Ph.D.

      Affiliations

    • Graduate School of Biomedical Sciences, Department of Radiology, Graduate School of Biomedical Science, Hiroshima University, Hiroshima, Japan
    • ,
  • Naoyuki Toyota, M.D., Ph.D.

      Affiliations

    • Graduate School of Biomedical Sciences, Department of Radiology, Graduate School of Biomedical Science, Hiroshima University, Hiroshima, Japan
    • ,
  • Hisaya Fujiwara, M.D., Ph.D.

      Affiliations

    • Department of Obstetrics and Gynecology, Hiroshima University, Hiroshima, Japan
    • ,
  • Yoshiki Kudo, M.D., Ph.D.

      Affiliations

    • Department of Obstetrics and Gynecology, Hiroshima University, Hiroshima, Japan
    • ,
  • Katsuhide Ito, M.D., Ph.D.

      Affiliations

    • Graduate School of Biomedical Sciences, Department of Radiology, Graduate School of Biomedical Science, Hiroshima University, Hiroshima, Japan

Received 3 December 2008 ,Revised 12 February 2009 ,Accepted 12 February 2009.

References 

  1. Percey R, Brundage M, Drouin P, et al. Phase III trial comparing radical radiotherapy with and without cisplatin chemotherapy in patients with advanced squamous cell cancer of the cervix. J Clin Oncol. 2002;20:966–972
  2. Percey R, Miao Q, Kong W, et al. Impact of adoption of chemotherapy on the outcome of cervical cancer in Ontario: Results of a population-based cohort study. J Clin Oncol. 2007;25:2383–2388
  3. Eifel PJ, Winter K, Morris M, et al. Pelvic irradiation with concurrent chemotherapy versus pelvic and para-aortic irradiation for high-risk cervical cancer: An update of Radiation Therapy Oncology group trial (RTOG) 90-01. J Clin Oncol. 2004;22:872–880
  4. Eifel PJ. Chemoradiotherapy in the treatment of cervical cancer. Semin Radiat Oncol. 2006;16:177–185
  5. Tseng CJ, Chang CT, Lai CH, et al. A randomized trial of concurrent chemoradiotherapy versus radiotherapy in advanced carcinoma of the uterine cervix. Gynecol Oncol. 1997;66:52–58
  6. Wong LC, Ngan HYS, Cheung ANY, et al. Chemoradiation and adjuvant chemotherapy in cervical cancer. J Clin Oncol. 1999;17:2055–2060
  7. Thomas G, Dembo A, Ackerman I, et al. A randomized trial of standard versus partially hyperfractionated radiation with or without concurrent 5-fluorouracil in locally advanced cervical cancer. Gynecol Oncol. 1998;69:137–145
  8. Lorvidhaya V, Chitapanarux I, Sangruchi S, et al. Concurrent mitomycin C, 5-fluorouracil, and radiotherapy in the treatment locally advanced carcinoma of the cervix: A randomized trial. Int J Clin Oncol. 2003;55:1226–1232
  9. Roberts KB, Urdaneta N, Vera R, et al. Interim results of a randomized trial of mitomycin C as an adjunct to radical radiotherapy in the treatment of locally advanced squamous-cell carcinoma of the cervix. Int J Cancer Radiat Oncol Invest. 2000;90:206–223
  10. Souhami L, Seymour R, Roman TN, et al. Weekly cisplatin plus external beam radiotherapy and high dose rate brachytherapy in patients with locally advanced carcinoma of the cervix. Int J Clin Oncol. 1993;27:871–878
  11. Chen SW, Liang JA, Hung YC, et al. Concurrent weekly cisplatin plus external beam radiotherapy and high-dose rate brachytherapy for advanced cervical cancer: A control cohort comparison with radiation alone on treatment outcome and complications. Int J Radiat Oncol Biol Phys. 2006;66:1370–1377
  12. Morris M, Eifel PJ, Lu J, et al. Pelvic radiation with concurrent chemoradiotherapy compared with pelvic and para-aortic radiation for high-risk cervical cancer. N Engl J Med. 1999;340:1137–1143
  13. Keys HM, Bundy BN, Stehman FB, et al. Cisplatin, radiation, and adjuvant hysterectomy compared with radiation and adjuvant hysterectomy for bulky stage Ib cervical carcinoma. N Engl J Med. 1999;340:1154–1161
  14. Rose PG, Bundy BN, Watkins EB, et al. Concurrent cisplatin-based radiotherapy for locally advanced cervical cancer. N Engl J Med. 1999;340:1144–1153
  15. Whitney CW, Sause W, Bundy BN, et al. Randomized comparison of fluorouracil plus cisplatin versus hydroxyurea as an adjunct to radiation therapy in stage IIB-IVA carcinoma of the cervix with negative para-aortic lymph nodes: A Gynecologic Oncology Group and Southwest Oncology Group study. J Clin Oncol. 1999;17:1339–1348
  16. Peters WA, Liu PY, Rolland PYL, et al. Concurrent chemotherapy and pelvic radiation therapy alone as adjuvant therapy after radical surgery in high-risk early-stage cancer of the cervix. J Clin Oncol. 2000;18:1606–1613
  17. Lin ZX, Qiao SM. Intraarterial cisplatin chemotherapy with surgery and/or radiotherapy in advanced cervical and vaginal carcinoma. Chin Med J. 1986;99:243–246
  18. Kavanagh JJ, Delclos L, Wallace S. Arterial chemotherapy prior to radiotherapy in advanced gynecologic cancer. In:  Rutledge FN,  Freedman RS editor. Gynecologic cancer: Diagnostic and treatment strategies. Austin, TX: University of Austin Press; 1987;p. 281–284
  19. Scarabelli C, Tumolo S, Paoli A, et al. Intermittent pelvic arterial infusion with peptichemio, doxorubicin, and cisplatin for locally advanced and recurrent carcinoma of the uterine cervix. Cancer. 1987;60:25–30
  20. LaPolla JP, Roberts WS, Greenberg H, et al. Treatment of advanced gynecologic malignancies with intraarterial chemotherapy and accelerated fractionation radiation therapy: A preliminary report. Gynecol Oncol. 1990;37:55–59
  21. Patton TJ, Kavanagh JJ, Delclos L, et al. Five-year survival in patients given intra-arterial chemotherapy prior to radiotherapy for advanced squamous carcinoma of the cervix and vagina. Gynecol Oncol. 1991;42:54–59
  22. Kigawa J, Kanamori Y, Ishikawa H, et al. Response rate and cell-cycle changes due to intra-arterial infusion chemotherapy with cisplatin and bleomycin for locally recurrent uterine cervical cancer. Am J Clin Oncol. 1996;19:255–259
  23. Sueyama H, Nakano M, Sakumoto K, et al. Intra-arterial chemotherapy with cisplatin followed by radical radiotherapy for locally advanced cervical cancer. Gynecol Oncol. 1994;59:327–332
  24. Takashima H, Hosokawa A, Hino I, et al. Results of radiotherapy for stage III uterine cervical carcinomas and preliminary study of combined radiotherapy and transarterial infusion chemotherapy. Nippon Acta Radiol. 1994;54:1270–1276
  25. Morris M, Eifel PJ, Burke TW, et al. Treatment of locally advanced cervical cancer with concurrent radiation and intra-arterial chemotherapy. Gynecol Oncol. 1995;57:72–78
  26. Roberts WS, LaPolla JP, Greenberg H, et al. Continuous intra-arterial cisplatin combined with radiotherapy in locally advanced squamous carcinoma of the cervix: A Gynecologic Oncology Group pilot study. Int J Gynecol Cancer. 1995;5:335–340
  27. Tuji K, Yamada R, Kawabata M, et al. Effect of balloon occluded arterial infusion of anticancer drugs on the prognosis of cervical cancer treated with radiation therapy. Int J Radiat Oncol Biol Phys. 1995;32:1337–1345
  28. Narimatsu A, Okada O, Itoh T. Neoadjuvant chemotherapy with continuous intra-arterial infusion (cisplatin, 5-fluorouracil) in the treatment of stage III cervical cancer. Gan To Kagaku Ryoho. 1995;22:2087–2093
  29. Toita T, Sakumoto K, Higashi M, et al. Therapeutic value of neoadjuvant intra-arterial chemotherapy (cisplatin) and irradiation for locally advanced uterine cervical cancer. Gynecol Oncol. 1997;65:421–424
  30. Sugiyama T, Nishida T, Hasuo Y, et al. Neoadjuvant intraarterial chemotherapy followed by radical hysterectomy and/or radiotherapy for locally advanced cervical cancer. Gynecol Oncol. 1998;69:130–136
  31. Kaneyasu Y, Kita M, Fukuhara N, et al. Clinical evaluation of intra-arterial infusion chemotherapy for advanced or recurrent cervical cancer. J Jpn Soc Ther Radiol Oncol. 1998;10:293–303
  32. Kokubo M, Tsutsui K, Nagata Y, et al. Radiotherapy combined with transcatheter arterial infusion chemotherapy for locally advanced cervical cancer. Acta Oncol. 1998;37:143–149
  33. Chaney AW, Eifel PJ, Lodsdon MD, et al. Mature results of a pilot study of pelvic radiotherapy with concurrent continuous infusion intra-arterial 5-FU for stage IIIB-IVA squamous cell carcinoma of the cervix. Int J Radiat Oncol Biol Phys. 1999;45:113–118
  34. Nagata Y, Okajima K, Kokubo M, et al. Clinical results of transcatheter arterial infusion for uterine cervical cancer. Am J Clin Oncol. 1999;22:97–102
  35. Onishi H, Yamaguchi M, Kuriyama K, et al. Effect of concurrent intra-arterial infusion of platinum drugs for patients with stage III or IV uterine cervical cancer treated with radical radiotherapy. Cancer J Sci Am. 2000;6:40–45
  36. Nagai N, Oshita T, Murakami J, et al. Radiotherapy combined with transcatheter arterial infusion of cisplatin versus oral fluoropyrimidine anti cancer agent for locally advanced carcinoma of the uterine cervix: A prospective follow up study. Oncol Rep. 2001;8:119–125
  37. Kawase S, Okuda T, Ikeda M, et al. Intraarterial cisplatin/nedaplatin and intravenous 5-fluorouracil with concurrent radiation therapy for patients with high-risk uterine cervical cancer. Gynecol Oncol. 2006;102:493–499
  38. Kim EE, Bledin AG, Kavanagh J, et al. Chemotherapy of cervical carcinoma: Use of Tc-99m-MAA infusion to predict drug distribution. Radiology. 1984;150:677–681
  39. Japan Society of Obstetrics and Gynecology, Japanese Society of Pathology, Japan Radiological Society. The general rules for clinical and pathological management of uterine cervical cancer. 2nd ed. Tokyo, Japan: Kanehara publication Co., Ltd; 1997;
  40. National Cancer Institute. Common Terminology Criteria for Adverse Events v3.0 (CTCAE). Publish Date: August 9, 2006. Available online at http://ctep.cancer.gov/protocol Development/electronic_applications/docs/ctcaev3.pdf. Accessed September 2, 2007.
  41. Akine Y, Arimoto H, Ogino T, et al. High-dose-rate intracavitary irradiation in the treatment of carcinoma of the uterine cervix: Early experience with 84 patients. Int J Radiat Oncol Biol Phys. 1988;14:893–898
  42. Arai T, Nakano T, Morita S, et al. High-dose-rate remote afterloading intracavitary radiation therapy for cancer of the uterine cervix. Cancer. 1992;69:175–180
  43. Nakano T, Kato S, Ohno T, et al. Long-term results of high-dose rate intracavitary brachytherapy for squamous cell carcinoma of the uterine cervix. Cancer. 2005;103:92–101
  44. Ito H, Kutuki S, Nishiguchi I, et al. Radiotherapy for cervical cancer with high-dose rate brachytherapy—correlation between tumor size, dose and failure. Radiother Oncol. 1994;31:241–247
  45. Teshima T, Inoue T, Ikeda H, et al. High-dose rate and low-dose rate intracavitary therapy for carcinoma of the uterine cervix: Final results of Osaka University Hospital. Cancer. 1993;72:2409–2414
  46. Hareyama M, Sakata K, Oouchi A, et al. High-dose-rate versus low-dose-rate intracavitary therapy for carcinoma of the uterine cervix. Cancer. 2007;1:117–124
  47. Okawa T, Kita M, Goto M, et al. Radiation therapy alone in the treatment of carcinoma of the uterine cervix: Review of experience at Tokyo Women's Medical College (1969-1983). Int J Radiat Oncol Biol Phys. 1987;13:1845–1849
  48. Sakata K, Sakurai H, Suzuki Y, et al. Results of concurrent chemoradiation for cervical cancer using high dose rate intracavitary brachytherapy: Study of JROSG (Japan Radiation Oncology Study Group). Acta Oncol. 2008;47:434–441

 Presented at the 5th Japan/US Cancer Therapy Symposium and the 5th Takahashi Memorial Joint Symposium, September 7–9, 2007, Sendai, Japan.

 Conflict of interest: none.

PII: S0360-3016(09)00860-8

doi: 10.1016/j.ijrobp.2009.02.081

International Journal of Radiation Oncology * Biology * Physics
Volume 75, Issue 2 , Pages 369-377 , 1 October 2009

Article Tools

* Image Usage & Resolution